Minimally oxidized low-density lipoprotein regulates hemostasis factors of brain capillary endothelial cells

Journal of the Neurological Sciences

Volumn 217, Issue 2, 2004, Pages 135-141

  Kim, Jeong Ai ^a   Tran, Nam D ^a   Berliner, Judith A ^b   Fisher, Mark J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Endothelium; Oxidized lipids; Thrombomodulin; Tissue plasminogen activator; Tissue plasminogen activator inhibitor 1

Indexed keywords

MESSENGER RNA; OXIDIZED LOW DENSITY LIPOPROTEIN; PLASMINOGEN ACTIVATOR; THROMBOMODULIN; TISSUE PLASMINOGEN ACTIVATOR;

ANIMAL CELL; ANTICOAGULATION; ARTICLE; BRAIN CAPILLARY; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; HEMOSTASIS; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; THROMBOGENESIS; VASCULAR ENDOTHELIUM;

EID: 0347357715     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2003.09.006     Document Type: Article

References (49)

1. Mendez I., Hachinski V., Wolfe B. Serum lipids after stroke. Neurology. 37:1987;507-511.
2. Delanty N., Vaughan C.J. Vascular effects of statins in stroke. Stroke. 28:1997;2315-2320.
3. Harrison D.G. Endothelial dysfunction in atherogenesis. Basic Res. Cardiol. 89:1994;87-102.
4. Steinberg D., Parthasarathy T.E., Carew T.E., Khoo J.C., Witztum J.L. Beyond cholesterol: modification of low density lipoprotein that increases its atherogenecity. N. Engl. J. Med. 320:1989;915-924.
5. Berliner J.A., Navab M., Fogelman A.M., Frank J.S., Demer L.L., Edwards P.A.et al. Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation. 91:1995;2488-2496.
6. Berliner J.A., Territo M.C., Sevanian A., Ramin S., Kim J.A., Bamshad B.et al. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions. J. Clin. Invest. 85:1990;1260-1266.
7. Ross R. The pathogenesis of atherosclerosis: an update. N. Engl. J. Med. 314:1986;488-500.
8. Drake T.A., Hannani K., Fei H., Lavi S., Berliner J.A. Minimally oxidized low-density lipoprotein induces tissue factor expression in cultured human endothelial cells. Am. J. Pathol. 138:1991;601-607.
9. Fei H., Berliner J.A., Parhami F., Drake T.A. Regulation of endothelial tissue factor expression by minimally oxidized LDL and lipopolysaccharide. Arterioscler. Thromb. 13:1993;1711-1717.
10. Galle J., Mulsch A., Busse R., Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelial-derived relaxing factor. Arterioscler. Thromb. 11:1991;198-203.
11. Napoli C., Paterno R., Faraci F., Taguchi H., Postiglione A., Heistad D. Mildly oxidized low-density lipoprotein impairs responses of carotid but not basilar artery in rabbits. Stroke. 28:1997;2266-2272.
12. Esmon C.T. The regulation of natural anticoagulant pathway. Science. 235:1987;1348-1352.
13. Dittman W.A., Majerus P.W. Structure and function of thrombomodulin: a natural anticoagulant. Blood. 75:1990;329-336.
14. Salem H.H., Maruyama I., Ishii H., Majerus P.W. Isolation and characterization of thrombomodulin from human placenta. J. Biol. Chem. 259:1984;12246-12251.
15. Weis J.R., Pitas R.E., Wilson B.D., Rogers G.M. Oxidized LDL increases cultured human endothelial cell tissue factor activity and reduces protein C activation. GM FASEB J. 5:1991;2459-2465.
16. Chautan Y.L.M., Anfosso F., Nalbone A.G., Lafont H., Juhan-Vague I. Stimulating effect of oxidized low density lipoproteins on plasminogen activator inhibitor-1 synthesis by endothelial cells. Arterioscler. Thromb. 11:1991;1821-1829.
17. Carson M.P., Haudenschild C.C. Microvascular endothelium and pericytes: high yield, low passage cultures. In Vitro Cell. Dev. Biol. 22:1986;344-354.
18. Tran N.D., Wong V.L.Y., Bready J., Schreiber S.S., Fisher M.J. Regulation of brain capillary endothelial thrombomodulin mRNA expression. Stroke. 27:1996;2304-2311.
19. Liao F., Berliner J.A., Mehrabian M., Navab M., Demer L., Lusis A.J.et al. MM-LDL is biologically active in vivo mice. J. Clin. Invest. 87:1991;2253-2257.
20. Kosugi K., Morel D.C., Dicorleto P.E., Chisolm G.M. Toxicity of oxidized LDL to cultured fibroblasts is selective for S phase of the cell cycle. J. Cell. Physiol. 130:1987;311-320.
21. Bodier C. Phase separation of integral membrane proteins in triton X-114 solution. J. Biol. Chem. 256:1981;1604-1607.
22. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
23. Tsiang M., Lentz S.R., Dittman W.A., Wen D., Scaarpati E.M., Sadler J.E. Equilibrium binding of thrombin to recombinant human thrombomodulin: effect of hirudin, fibrinogen, factor Va, and peptide analogues. Biochemistry. 29:1990;10602-10612.
24. Tran N.D., Correale J., Schreiber S.S., Fisher M. Transforming growth factor-β mediates astrocyte-specific regulation of brain capillary endothelial anticoagulant factors. Stroke. 30:1999;1671-1677.
25. Tran N.D., Wang L., Schreiber S.S., Zlokovic B., Fisher M. Measurement of thrombomodulin mRNA expression in brain capillaries by polymerase chain reaction. Thromb. Res. 91:1998;191-197.
26. Jensen L.E., Whitehead A.S. Competitive reverse transcription polymerase chain reaction for qualifying pre-mRNA and mRNA of major acute phase proteins. J. Immunol. Methods. 215:1998;45-58.
27. Tran N.D., Schreiber S.S., Fisher M. Astrocyte regulation of endothelial tissue plasminogen activator in a blood-brain barrier model. J. Cereb. Blood Flow Metab. 18:1998;1316-1324.
28. Van Berkel T.J., de Rijke Y.B., Kruijt J.K. Different fate in vivo of oxidatively modified low density lipoprotein and acetylated low density lipoproteins in rats. Recognition by various scavenger receptors on Kupffer and endothelial liver cells. J. Biol. Chem. 266:1991;2282-2289.
29. Nordestgaard B.G. The vascular endothelial barrier-selective retention of lipoproteins. Curr. Opin. Lipidol. 7:1996;269-273.
30. Juul K., Nielsen L.B., Munkholm K., Stender S., Nordestgaard B.G. Oxidation of plasma low density lipoprotein accelerates its accumulation and degradation in the arterial wall in vivo. Circulation. 94:1996;1698-1704.
31. Lucarelli M., Borrelli V., Fiori A., Cucina A., Granata F., Potenza R.L.et al. The expression of native and oxidized LDL receptors in brain microvessels is specifically enhanced by astrocytes-derived soluble factor(s). FEBS Letters. 522:2002;19-23.
32. Steinberg D. Low density lipoprotein oxidation and its pathological significance. J. Biol. Chem. 272:1997;20963-20966.
33. Moore K.L., Esmon C.T., Esmon N.L. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 73:1989;159-165.
34. Nawroth P.P., Stern D.M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J. Exp. Med. 163:1986;740-745.
35. Conway E.M., Rosenberg R.D. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol. Cell Biol. 8:1988;5588-5592.
36. Lentz S.R., Tsiang M., Sadler J.E. Regulation of thrombomodulin by tumor necrosis factor-alpha: comparison of transcriptional and posttranscriptional mechanisms. Blood. 77:1991;542-550.
37. Garcia-Malsonado M., Kaufman C.E., Comp P.C. Decrease in endothelial cell-dependent protein C activation induced by thrombomodulin by treatment with cyclosporine. Transplantation. 51:1991;701-705.
38. Lentz S.R., Sadler J.E. Inhibition of thrombomodulin surface expression and protein C activation by the thrombogenic agent homocysteine. J. Clin. Invest. 88:1991;1906-1914.
39. Hayashi T., Honda T., Suzuki K. An atherogenic stimulus homocysteine inhibits cofactor activity of thrombomodulin and enhances thrombomodulin expression in human umbilical vein endothelial cells. Blood. 79:1992;2930-2936.
40. Ogawa S., Gerlach H., Esposito C., Pasagian-Macaulay A., Brett J., Stern D. Hypoxia modulates the barrier and coagulant function of cultured bovine endothelium. Increased monolayer permeability and induction of procoagulant properties. J. Clin. Invest. 85:1990;1090-1098.
41. Ishii H., Kizaki K., Horie S., Kazama M. Oxidized low density lipoprotein reduced thrombomodulin transcription in cultured human endothelial cells through degradation of the lipoprotein in lysosomes. J. Biol. Chem. 271:1996;8458-8465.
42. Lentz S.R., Fernandez J.A., Griffin J.H., Piegors D.J., Erger R.A., Malinow M.R.et al. Impaired anticoagulant response to infusion of thrombin in atherosclerotic monkeys associated with acquired defects in the protein C system. Arterioscler. Thromb. Vasc. Biol. 19:1999;1744-1750.
43. Kugiyama K., Sakamoto T., Misumi I., Sugiyama S., Ohgushi M., Ogawa H.et al. Transferable lipids in oxidized low density lipoprotein stimulate plasminogen activator inhibitor-1 and inhibit tissue-type plasminogen activator release from endothelial cells. Circ. Res. 73:1993;335-343.
44. Nordt T.K., Peter K., Ruef J., Kübler W., Bode C. Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease. Thromb. Haemost. 82:1999;14-18.
45. Salomaa V., Matei C., Aleksic N., Sansores-Garcia L., Folsom A.R., Juneja H.et al. Soluble thrombomodulin as a predictor of incident coronary heart disease and symptomless carotid artery atherosclerosis in the atherosclerosis risk in communities (ARIC) study: a case-cohort study. Lancet. 353:1999;1729-1734.
46. Lindgren A., Lindoff C., Norrving B., Astedt B., Johansson B.B. Tissue plasminogen activator and plasminogen activator-1 in stroke patients. Stroke. 27:1996;1066-1071.
47. Thögersen A.M., Jansson J.H., Boman K., Nilsson T.K., Weinehall L., Huhtasaari F.et al. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in men and women: evidence for the fibrinolytic system as an independent primary risk factor. Circulation. 98:1998;2141-2147.
48. Johansson L., Jansson J.H., Boman K., Nilsson T.K., Stegmayr B., Hallmans G. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke. Stroke. 31:2000;26-32.
49. Gottsauner-Wolf M., Sochor H., Hornykewycz S., Beckmann R., Lang I., Probst P.et al. Predictive value of PAI-1 plasma activity and the thallium perfusion imaging for restenosis after percutaneous transluminal angioplasty in clinically asymptomatic patients. Thromb. Haemost. 81:1999;522-526.